Alzheimer's activists to demonstrate at FDA
Executive Summary
Volunteers representing Alzheimer's patients will hold a demonstration Sept. 24 at FDA's 200 C St. building, near the U.S. Capitol, to urge FDA to approve quickly anti-dementia drugs such as Warner-Lambert's Cognex (tacrine). The demonstration is being organized by William Summers, MD, who in 1986 reported the first clinical results with tacrine in a letter to the New England Journal of Medicine. FDA later concluded that the study was seriously flawed. Summers will present petitions demanding immediate action on Cognex and/or a congressional hearing on delays in the drug's approval.